Menu
Currency
GWAS Study

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.

Jin Y, Birlea SA, Fain PR et al.

20410501 PubMed ID
GWAS Study Type
7656 Participants
61 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JY
Jin Y
BS
Birlea SA
FP
Fain PR
GK
Gowan K
RS
Riccardi SL
HP
Holland PJ
MC
Mailloux CM
SA
Sufit AJ
HS
Hutton SM
AA
Amadi-Myers A
BD
Bennett DC
WM
Wallace MR
MW
McCormack WT
KE
Kemp EH
GD
Gawkrodger DJ
WA
Weetman AP
PM
Picardo M
LG
Leone G
TA
Taïeb A
JT
Jouary T
EK
Ezzedine K
VG
van Geel N
LJ
Lambert J
OA
Overbeck A
SR
Spritz RA
Chapter II

Abstract

Summary of the research findings

Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which results in patchy depigmentation of skin and hair, and is associated with an elevated risk of other autoimmune diseases.

1,392 European ancestry cases, 2,629 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

7656
Total Participants
GWAS
Study Type
Yes
Replicated
647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 1,383 European ancestry individuals from 332 families
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.